Jan 19, 2017 7:43 am EST Abeona Therapeutics Receives Orphan Drug Designation in The European Union for ABO-101 Gene Therapy in Sanfilippo Syndrome Type B
Jan 17, 2017 7:53 am EST Abeona Therapeutics to Present at Phacilitate Cell & Gene Therapy World 2017
Jan 3, 2017 7:43 am EST Abeona Therapeutics Receives Orphan Drug Designation in The European Union for ABO-201 Gene Therapy Program in Juvenile Batten Disease
Dec 6, 2016 7:43 am EST Abeona Therapeutics to Present at 2016 Genetic Rx Boston Biotech Conference at Harvard Medical School
Nov 15, 2016 7:58 am EST Abeona Therapeutics to Present at World Orphan and Drug Congress Europe 2016
Nov 10, 2016 7:43 am EST Abeona Therapeutics Announces Third Quarter 2016 Financial Results and Recent Clinical Highlights
Nov 5, 2016 2:03 pm EDT Abeona Therapeutics Honored with Partner in Progress Award from DEBRA of America
Nov 3, 2016 7:43 am EDT Abeona Therapeutics to Present at Alliance of Regenerative Medicine 4th Annual Advanced Therapies Investor Day in London, UK
Nov 2, 2016 8:03 am EDT Abeona Therapeutics Announces JAMA Publication of Positive Phase 1 Study Results for EB-101 Gene Therapy Clinical Trial for Epidermolysis Bullosa
Nov 1, 2016 10:23 am EDT Abeona Therapeutics Inc. Announces Closing of its Underwritten Offering of Common Stock
